Several minimally invasive treatments have been developed to treat benign prostatic obstruction (BPO) via a transurethral approach, with a non-negligible risk of complications such as urethral stricture and external sphincter damage.
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
